Genmab A/S (CPH:GMAB)
Denmark
· Delayed Price · Currency is DKK 1,789.00
-51.50 (-2.80%)
Sep 29, 2025, 1:13 PM CET
Genmab Market Cap
Genmab has a market cap or net worth of 113.29 billion as of September 29, 2025. Its market cap has decreased by -3.73% in one year.
Market Cap
113.29B
Enterprise Value
95.82B
Revenue
23.16B
Ranking
n/a
PE Ratio
13.40
Stock Price
1,789.00
Market Cap Chart
Since October 18, 2000, Genmab's market cap has increased from 3.68B to 113.29B, an increase of 2,975.06%. That is a compound annual growth rate of 14.71%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1,548.54B |
| Coloplast | 123.98B |
| Demant | 48.10B |
| ALK-Abelló | 44.68B |
| H. Lundbeck | 42.17B |
| Zealand Pharma | 30.91B |
| Ambu A/S | 24.83B |
| Bavarian Nordic | 17.84B |